Clinical trial for Cardioversion
Official title MAX - SHOCK Clinical Trial
ClinicalTrials.gov ID: NCT06556667
What this study is testing
- What it's testing
- The study wants to see if using a higher‑energy (360 J) biphasic defibrillator improves the success rate of electrical cardioversion compared with a lower‑energy (200 J) device.
- Who it's for
- Adults who have atrial fibrillation and are planned to undergo electrical cardioversion.
- What's involved
- Participants will have a single electrical cardioversion using either the 360 J or the 200 J biphasic defibrillator, with standard monitoring and follow‑up to check if normal rhythm is restored.
- Time commitment
- One treatment visit (the cardioversion procedure) with brief post‑procedure monitoring.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients age \> 18 years.
- Persistent atrial fibrillation.
- Scheduled for elective cardioversion at UOHI
- Patient is within the circle of care of UOHI Electrophysiology staff
You likely can't join if
- Known left-atrial appendage thrombus.
- Contraindication to appropriate anticoagulation.
- Patient is included in another assigned by chance clinical trial.
- Patient does not meet all of the above listed inclusion criteria.
The study team makes the final eligibility decision.
Where it is enrolling
- Ottawa, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ottawa, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.